Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.

Helen KovariB SurialP E TarrM CavassiniA CalmyP SchmidE BernasconiA RauchG WandelerB Ledergerbernull null

Published in: HIV medicine (2021)

Replacing TDF with TAF in HIV-monoinfected people led to a significant decrease in ALT values. Findings were not significantly affected by known risk factors for hepatotoxicity.

Keyphrases

hiv positive
antiretroviral therapy
hiv infected
human immunodeficiency virus
men who have sex with men
hiv aids
south africa
hiv testing
sars cov
hepatitis c virus
drug induced